南方财经全媒体记者 李依农 上海报道

In a recent interview with SFC, Mike Crichton, senior vice president of GSK, highlighted the compelling impact of China's continuous reform and opening-up. According to Crichton, this transformative process has not only attracted a surge of international pharmaceutical companies and investors into the Chinese market, but also positioned them to harness the immense potential of China's vast economic landscape. 

【资料图】

Speaking on the matter, Crichton remarked, "The vibe of innovation, the development potential, and the growth momentum in Chinese healthcare are truly impressive, which makes me fully confident about our future here in China." 

策划：于晓娜   

监制：施诗

责任编辑：和佳

记者：季媛媛 李依农

制作：实习生蔡于恬

设计：梁俏

新媒体统筹：丁青云 曾婷芳 赖禧 黄达迅

海外运营监制: 黄燕淑

海外运营内容统筹: 张然

海外运营编辑：唐双艳 吴婉婕

海外项目经理：庄欢

海外商务合作: 黄子豪

出品：南方财经全媒体集团